Mckesson Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
McKesson (MCK)
Track today's live McKesson (MCK) share price, performance and key data on this page with our current NYSE:MCK stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the McKesson share price on the NYSE exchange. Use the dropdown to switch exchange for the MCK share price, head to our technical summary section, which provides analysis on McKesson share price buy/sell indicators using real-time data (or discuss the McKesson (MCK) stock price today with other investors in the McKesson NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE:MCK share price (ISIN: US58155Q1031) to enhance your trading decisions with our free investment tools and resources.
What Is the McKesson Share Price Today?
The McKesson share price today is 901.77.
What Is the Stock Symbol for McKesson
The stock symbol (or 'ticker') for McKesson Corporation is "MCK."
What Stock Exchange Does McKesson Trade On?
McKesson Corporation is listed and trades on the NYSE stock exchange.
Is McKesson a Good Stock to Buy?
Determining whether McKesson (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NYSE:MCK share price (ISIN: US58155Q1031) to enhance your trading decisions with our free investment tools and resources.
What Is the McKesson Share Price Today?
The McKesson share price today is 901.77.
What Is the Stock Symbol for McKesson
The stock symbol (or 'ticker') for McKesson Corporation is "MCK."
What Stock Exchange Does McKesson Trade On?
McKesson Corporation is listed and trades on the NYSE stock exchange.
Is McKesson a Good Stock to Buy?
Determining whether McKesson (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
877.33
902.05
52 wk Range
659.86
999.00
MCK is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
877.33902.05
52 wk Range
659.86999.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MCK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
991.40
Upside
+9.94%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 18 consecutive years
Mckesson Corp receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Mckesson Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mckesson Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Mckesson Corp receives Investment Bank Analyst Rating Update- Investing.com
Pro
Mckesson Corp receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
14 Buy
3 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 991.40
(+9.94% Upside)
McKesson Corporation SWOT Analysis
Oncology Powerhouse | McKesson's strategic focus on oncology and biopharma services positions it for sustainable double-digit growth in high-value healthcare segments |
Acquisition Spree | Explore McKesson's bold moves in acquiring oncology assets, including a $2.49 billion stake in Florida Cancer Specialists, enhancing market position |
Financial Resilience | Learn how McKesson's strong US Pharma segment performance and raised guidance reflect its robust financial health and growth potential |
Data-Driven Future | Delve into McKesson's enhanced data capabilities from recent acquisitions, potentially unlocking new revenue streams and competitive advantages |
McKesson Corporation Earnings Call Summary for Q1/2027
- McKesson reported Q1 FY2027 adjusted EPS of $9.93, beating estimates of $9.64, with revenue rising 8% to $105.38B, exceeding the $103.82B forecast.
- The company raised full-year adjusted EPS guidance to $44.20-$45.00 from $43.80-$44.60, implying 13%-15% growth driven by strong operational performance.
- North American Pharmaceutical and Oncology segments led growth with 19% and 41% operating profit gains respectively, supported by specialty drug distribution.
- The board approved a 15% dividend increase, marking the 10th consecutive annual raise, while maintaining plans for $5B in share repurchases for the year.
- Stock surged 8.24% to $898.87 in after-hours trading, nearing its 52-week high of $999, as investors welcomed the earnings beat and raised outlook.
Last Updated: 05/08/2026, 22:46
Read Full TranscriptEarnings
Latest Release
05/08/2026
EPS / Forecast
9.93 / 9.64
Revenue / Forecast
105.38B / 103.82B
Compare MCK to Peers and Sector
Metrics to compare | MCK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMCKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 22.9x | 48.7x | −0.4x | |
PEG Ratio | 0.46 | −0.48 | 0.00 | |
Price/Book | −24.8x | 1.9x | 2.6x | |
Price / LTM Sales | 0.3x | 0.9x | 3.1x | |
Upside (Analyst Target) | 10.9% | 0.0% | 47.5% | |
Fair Value Upside | Unlock | 5.2% | 5.9% | Unlock |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the McKesson (NYSE: MCK) Share Price Today?
The McKesson stock price today is 901.77 USD.
What Stock Exchange Does McKesson (MCK) Trade On?
McKesson is listed and trades on the New York Stock Exchange.
What Is the Ticker (Stock Symbol) for McKesson?
The stock symbol (also called a 'ticker') for McKesson is "MCK."
Does McKesson Pay Dividends? What’s The Current MCK Dividend Yield?
Yes, MCK Pays Dividends to its Shareholders. The current McKesson dividend yield is 0.43%.
What Is the Current McKesson Market Capitalisation?
As of today, McKesson (NYSE: MCK) market cap is 105.14B USD.
What Is McKesson's (MCK) Earnings Per Share (TTM)?
The McKesson EPS is currently 37.48 (Trailing Twelve Months).
When Is the Next McKesson Earnings Date?
McKesson's next earnings report will be released on 03/11/2026.
Is MCK a Buy or Sell From a Technical Analyst Perspective?
Based on today's McKesson moving averages and other technical indicators, the daily buy/sell signal for MCK stock is Strong Buy.
How Many Times Has McKesson Stock Split?
McKesson has split 2 times. (See the MCK stock split history page for full effective split date and price information.)
How Many Employees Does McKesson Have?
McKesson has 42300 employees, based on their latest Companies House report.
What is the current trading status of McKesson (NYSE: MCK)?
As of 12/08/2026, McKesson (MCK) is trading at a share price of 901.77 USD, with a previous close of 879.87 USD. The stock has fluctuated within a day range of 877.33 USD to 902.05 USD, while its 52-week range spans from 659.86 USD to 999.00 USD.
What Is McKesson (MCK) Price Target According to Analysts?
The average 12-month price target for McKesson is 991.40 USD, with a high estimate of 1080 USD and a low estimate of 905 USD. 14 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +9.94% Upside potential.
What Is the MCK Premarket Price?
MCK's last pre-market stock price is 879.00 USD. The pre-market share volume is 4,430.00, and the stock has decreased by -0.87, or -0.10%.
What Is the MCK After Hours Price?
MCK's last after hours stock price is 899.06 USD, the stock has decreased by -2.71, or -0.30%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.